An Algorithm for Predicting Blood Loss and Transfusion Risk in Fast Track Total Hip Arthroplasty
NCT ID: NCT02750852
Last Updated: 2016-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
124 participants
OBSERVATIONAL
2016-04-30
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
THRA_hematologic Variables
NCT01521858
Effect of Surgical Approach on Postoperative Bleeding in Patien Arthroplasty
NCT06308003
Total Hip Arthroplasty: Fast Track Protocol is the Future?
NCT03875976
Revision Total Hip Replacement Arthroplasty and Hematologic Variables
NCT02951741
Assessment of Blood Loss With a Point Of Care Device
NCT01430273
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Analysis group
Create an algorithm to predict blood loss using patients data
Total hip arthroplasty, blood loss analysis
Data analysis about blood loss in total hip replacement
Control group
The algorithm was applied to analyze sensitivity and specificity
Total hip arthroplasty, blood loss analysis
Data analysis about blood loss in total hip replacement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total hip arthroplasty, blood loss analysis
Data analysis about blood loss in total hip replacement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Active treatment with warfarin
* Coagulation disorders
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliera Bolognini di Seriate Bergamo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Riccardo Compagnoni
Medical doctor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Blood algorithm
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.